The role of prophylactic central compartment lymph node dissection in elderly patients with differentiated thyroid cancer: a multicentric study.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
24 Apr 2019
Historique:
received: 26 09 2018
accepted: 29 10 2018
entrez: 11 5 2019
pubmed: 11 5 2019
medline: 3 7 2019
Statut: epublish

Résumé

Prophylactic central neck lymph-nodes dissection is still a topic of major debate in Literature. There is a lack of randomized controlled trials proving advantages in its application in terms of overall survival and local recurrence. Due to the recent rapid increase of elderly population, differentiated tumor carcinoma diagnosis increased in patients over 65 years old. The aim of this study was to compare recurrence rate, complications rate and histological features of tumors in elderly population. A retrospective study was carried out collecting data from 371 patients with differentiated thyroid cancer without clinical evidence of lymph-nodes involvement in three Italian referral centers from 2005 to 2015. All patients were aged ≥ 65 years and were divided in two groups based on the performed surgery (total thyroidectomy alone or associated with central lymph-nodes dissection). Moreover, patients were stratified according to the age between 65 and 74 years old and over 75 years old. Total thyroidectomy alone was performed in 184 patients (group A) and total thyroidectomy with prophylactic central neck dissection was performed in 187 cases (group B). There was a statistically significant difference in complications between the groups in terms of neck hematoma (0.5% group A vs 3.7% group B), temporary hypoparathyroidism (11.4% group A vs 21.4% group B), and temporary unilateral recurrent nerve injury (1.5% group A vs 6.4% group B). Lymph nodes recurrence rate was 9.2% in group A and 8.5% in group B, with no statistically significant difference. There was a statistically significant difference in patients over 75 years old in terms of temporary hypoparathyroidism (24% group A vs 11% group B), permanent hypoparathyroidism (2,7% group A vs 0,3% group B) and recurrent nerve injury (9,5% group A vs 2% group B). The role of prophylactic central neck dissection is still controversial, especially in elderly patients, and an aggressive surgical approach should be carefully evaluated. The Authors reported a similar low recurrence rate between total thyroidectomy and total thyroidectomy associated with prophylactic central neck dissection, with increased postoperative complications in the lymphadenectomy group and in patients over 75 years old, advocating a tailored surgical approach in elderly population.

Sections du résumé

BACKGROUND BACKGROUND
Prophylactic central neck lymph-nodes dissection is still a topic of major debate in Literature. There is a lack of randomized controlled trials proving advantages in its application in terms of overall survival and local recurrence. Due to the recent rapid increase of elderly population, differentiated tumor carcinoma diagnosis increased in patients over 65 years old. The aim of this study was to compare recurrence rate, complications rate and histological features of tumors in elderly population.
METHODS METHODS
A retrospective study was carried out collecting data from 371 patients with differentiated thyroid cancer without clinical evidence of lymph-nodes involvement in three Italian referral centers from 2005 to 2015. All patients were aged ≥ 65 years and were divided in two groups based on the performed surgery (total thyroidectomy alone or associated with central lymph-nodes dissection). Moreover, patients were stratified according to the age between 65 and 74 years old and over 75 years old.
RESULTS RESULTS
Total thyroidectomy alone was performed in 184 patients (group A) and total thyroidectomy with prophylactic central neck dissection was performed in 187 cases (group B). There was a statistically significant difference in complications between the groups in terms of neck hematoma (0.5% group A vs 3.7% group B), temporary hypoparathyroidism (11.4% group A vs 21.4% group B), and temporary unilateral recurrent nerve injury (1.5% group A vs 6.4% group B). Lymph nodes recurrence rate was 9.2% in group A and 8.5% in group B, with no statistically significant difference. There was a statistically significant difference in patients over 75 years old in terms of temporary hypoparathyroidism (24% group A vs 11% group B), permanent hypoparathyroidism (2,7% group A vs 0,3% group B) and recurrent nerve injury (9,5% group A vs 2% group B).
CONCLUSIONS CONCLUSIONS
The role of prophylactic central neck dissection is still controversial, especially in elderly patients, and an aggressive surgical approach should be carefully evaluated. The Authors reported a similar low recurrence rate between total thyroidectomy and total thyroidectomy associated with prophylactic central neck dissection, with increased postoperative complications in the lymphadenectomy group and in patients over 75 years old, advocating a tailored surgical approach in elderly population.

Identifiants

pubmed: 31074400
doi: 10.1186/s12893-018-0433-0
pii: 10.1186/s12893-018-0433-0
pmc: PMC7402571
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

110

Références

N Engl J Med. 2001 Aug 16;345(7):512-6
pubmed: 11519506
Endocrine. 2017 Feb;55(2):530-538
pubmed: 27075721
Surgery. 2014 Jul;156(1):137-46
pubmed: 24878458
Epidemiol Prev. 2014 Mar-Apr;38(2 Suppl 1):5-7
pubmed: 24986497
World J Surg Oncol. 2016 May 17;14:149
pubmed: 27185169
Thyroid. 2015 Jul;25(7):760-8
pubmed: 26058403
Thyroid. 2016 Feb;26(2):256-61
pubmed: 26563459
Acta Medica (Hradec Kralove). 2017;60(1):44-50
pubmed: 28591551
Age Ageing. 2017 Dec 29;47(4):508-511
pubmed: 29300808
Ann Oncol. 2012 Oct;23 Suppl 7:vii110-9
pubmed: 22997443
World J Surg Oncol. 2016 Sep 19;14(1):247
pubmed: 27644091
Am J Surg. 2010 Oct;200(4):467-72
pubmed: 20887839
Thyroid. 2017 Oct;27(10):1285-1290
pubmed: 28741452
J Surg Res. 2017 May 1;211:228-232
pubmed: 28501122
N Engl J Med. 1994 Nov 10;331(19):1249-52
pubmed: 7935681
Thyroid. 2006 Nov;16(11):1151-5
pubmed: 17123342
Surgery. 2008 Dec;144(6):1070-7; discussion 1077-8
pubmed: 19041020
Int J Surg. 2014;12 Suppl 2:S140-S143
pubmed: 25183640
J Clin Endocrinol Metab. 2010 May;95(5):2187-94
pubmed: 20332244
BMC Surg. 2013;13 Suppl 2:S3
pubmed: 24267409
Endocr J. 2009;56(2):177-92
pubmed: 18703852
J Pathol Transl Med. 2016 Jul;50(4):278-86
pubmed: 27271109
Endocr J. 2014;61(4):403-8
pubmed: 24476946
Bull Cancer. 2017 Jun;104(6):516-523
pubmed: 28476312
Ann Surg Oncol. 2015 Feb;22(2):446-53
pubmed: 25190130
World J Surg. 2005 Nov;29(11):1497-501; discussion 1502-3
pubmed: 16222446
Medicine (Baltimore). 2016 Nov;95(47):e5450
pubmed: 27893690
G Chir. 2012 Oct;33(10):339-42
pubmed: 23095564
Clin Endocrinol (Oxf). 2014 Jul;81 Suppl 1:1-122
pubmed: 24989897
Eur J Surg Oncol. 2017 Jan;43(1):126-132
pubmed: 27780677
Ultrasonography. 2017 Oct;36(4):355-362
pubmed: 28513128
Br J Surg. 2014 Jun;101(7):883
pubmed: 24817656
J Natl Compr Canc Netw. 2014 Dec;12(12):1671-80; quiz 1680
pubmed: 25505208
Surgery. 2012 Aug;152(2):145-51
pubmed: 22503316
Surgery. 2014 Jun;155(6):998-1005
pubmed: 24856120
Thyroid. 2009 Jul;19(7):683-9
pubmed: 19583485
Thyroid. 2014 Jan;24(1):27-34
pubmed: 24001104
J Am Geriatr Soc. 2015 May;63(5):932-7
pubmed: 25945593
J Clin Endocrinol Metab. 2009 Apr;94(4):1086-8
pubmed: 19349473
N Engl J Med. 1998 Jan 29;338(5):297-306
pubmed: 9445411
Cancer. 2006 Feb 1;106(3):524-31
pubmed: 16369995
Endocrine. 2014 Nov;47(2):380-8
pubmed: 24718845
J Surg Oncol. 2006 Mar 1;93(3):194-8
pubmed: 16482598
Eur J Surg Oncol. 2017 Nov;43(11):1989-2000
pubmed: 28807633
Eur J Endocrinol. 2013 Mar 15;168(4):549-56
pubmed: 23337385
J Clin Endocrinol Metab. 2017 Feb 1;102(2):661-671
pubmed: 27849428
Ann Surg Oncol. 2013 Jul;20(7):2285-9
pubmed: 23417435
J Surg Oncol. 2004 Dec 15;88(4):217-22
pubmed: 15565630
Int J Surg. 2014;12 Suppl 1:S194-7
pubmed: 24862675

Auteurs

Claudio Gambardella (C)

Division of General and Oncologic Surgery, Department of Traslational Medical Sciences, University of Campania "Luigi Vanvitelli", School of Medicine, Via Sergio Pansini 5, 80131, Naples, Italy. claudiog86@hotmail.it.

Renato Patrone (R)

Division of General and Oncologic Surgery, Department of Traslational Medical Sciences, University of Campania "Luigi Vanvitelli", School of Medicine, Via Sergio Pansini 5, 80131, Naples, Italy.

Francesco Di Capua (F)

Division of General and Oncologic Surgery, Department of Traslational Medical Sciences, University of Campania "Luigi Vanvitelli", School of Medicine, Via Sergio Pansini 5, 80131, Naples, Italy.

Chiara Offi (C)

Division of General and Oncologic Surgery, Department of Traslational Medical Sciences, University of Campania "Luigi Vanvitelli", School of Medicine, Via Sergio Pansini 5, 80131, Naples, Italy.

Claudio Mauriello (C)

Division of General and Oncologic Surgery, Department of Traslational Medical Sciences, University of Campania "Luigi Vanvitelli", School of Medicine, Via Sergio Pansini 5, 80131, Naples, Italy.

Guglielmo Clarizia (G)

Division of General and Oncologic Surgery, Department of Traslational Medical Sciences, University of Campania "Luigi Vanvitelli", School of Medicine, Via Sergio Pansini 5, 80131, Naples, Italy.

Claudia Andretta (C)

Division of General and Oncologic Surgery, Department of Traslational Medical Sciences, University of Campania "Luigi Vanvitelli", School of Medicine, Via Sergio Pansini 5, 80131, Naples, Italy.

Andrea Polistena (A)

Endocrine Surgery Unit, University of Perugia, Piazza dell'Università, 06123, Perugia, Italy.

Alessandro Sanguinetti (A)

Endocrine Surgery Unit, University of Perugia, Piazza dell'Università, 06123, Perugia, Italy.

Pietrogiorgio Calò (P)

Department of Surgical Sciences, University of Cagliari, Cagliari, Italy.

Giovanni Docimo (G)

Division of General and Oncologic Surgery, Department of Traslational Medical Sciences, University of Campania "Luigi Vanvitelli", School of Medicine, Via Sergio Pansini 5, 80131, Naples, Italy.

Nicola Avenia (N)

Endocrine Surgery Unit, University of Perugia, Piazza dell'Università, 06123, Perugia, Italy.

Giovanni Conzo (G)

Division of General and Oncologic Surgery, Department of Traslational Medical Sciences, University of Campania "Luigi Vanvitelli", School of Medicine, Via Sergio Pansini 5, 80131, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH